[
  {
    "name": "Olaparib + Sapacitabine in BRCA Mutant Breast Cancer",
    "start_date": "2019-01-01",
    "end_date": "2025-08-01",
    "sponsor": "Sanofi"
  },
  {
    "name": "Topical Calcipotriene Treatment for Breast Cancer Immunoprevention",
    "start_date": "2018-03-20",
    "end_date": "2022-09-10",
    "sponsor": "Sanofi"
  },
  {
    "name": "Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer",
    "start_date": "2016-03-08",
    "end_date": "2026-10-10",
    "sponsor": "AstraZeneca"
  }
]
